BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20142802)

  • 1. 3D Telomere FISH defines LMP1-expressing Reed-Sternberg cells as end-stage cells with telomere-poor 'ghost' nuclei and very short telomeres.
    Knecht H; Sawan B; Lichtensztejn Z; Lichtensztejn D; Mai S
    Lab Invest; 2010 Apr; 90(4):611-9. PubMed ID: 20142802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells.
    Knecht H; Johnson NA; Haliotis T; Lichtensztejn D; Mai S
    Lab Invest; 2017 Jul; 97(7):772-781. PubMed ID: 28436953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D structural and functional characterization of the transition from Hodgkin to Reed-Sternberg cells.
    Knecht H; Brüderlein S; Mai S; Möller P; Sawan B
    Ann Anat; 2010 Sep; 192(5):302-8. PubMed ID: 20810259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D nuclear organization of telomeres in the Hodgkin cell lines U-HO1 and U-HO1-PTPN1: PTPN1 expression prevents the formation of very short telomeres including "t-stumps".
    Knecht H; Brüderlein S; Wegener S; Lichtensztejn D; Lichtensztejn Z; Lemieux B; Möller P; Mai S
    BMC Cell Biol; 2010 Dec; 11():99. PubMed ID: 21144060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of 3D Telomere FISH for the Characterization of the Nuclear Architecture in EBV-Positive Hodgkin's Lymphoma.
    Knecht H; Mai S
    Methods Mol Biol; 2017; 1532():93-104. PubMed ID: 27873269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LMP1 and Dynamic Progressive Telomere Dysfunction: A Major Culprit in EBV-Associated Hodgkin's Lymphoma.
    Knecht H; Mai S
    Viruses; 2017 Jun; 9(7):. PubMed ID: 28654015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 3D nuclear organization of telomeres marks the transition from Hodgkin to Reed-Sternberg cells.
    Knecht H; Sawan B; Lichtensztejn D; Lemieux B; Wellinger RJ; Mai S
    Leukemia; 2009 Mar; 23(3):565-73. PubMed ID: 19039323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the LMP1 oncoprotein in the EBV negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology.
    Knecht H; McQuain C; Martin J; Rothenberger S; Drexler HG; Berger C; Bachmann E; Kittler EL; Odermatt BF; Quesenberry PJ
    Oncogene; 1996 Sep; 13(5):947-53. PubMed ID: 8806684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of cyclin a correlates with morphogenesis of reed-sternberg cells in Hodgkin lymphoma.
    Chang KC; Chang Y; Jones D; Su IJ
    Am J Clin Pathol; 2009 Jul; 132(1):50-9. PubMed ID: 19864233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic chromosomal rearrangements in Hodgkin's lymphoma are due to ongoing three-dimensional nuclear remodeling and breakage-bridge-fusion cycles.
    Guffei A; Sarkar R; Klewes L; Righolt C; Knecht H; Mai S
    Haematologica; 2010 Dec; 95(12):2038-46. PubMed ID: 20823137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
    Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
    Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of oncogenic properties and nuclear factor-kappaB activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytes.
    Faumont N; Chanut A; Benard A; Cogne N; Delsol G; Feuillard J; Meggetto F
    Haematologica; 2009 Mar; 94(3):355-63. PubMed ID: 19211641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma.
    Gulley ML; Glaser SL; Craig FE; Borowitz M; Mann RB; Shema SJ; Ambinder RF
    Am J Clin Pathol; 2002 Feb; 117(2):259-67. PubMed ID: 11863222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
    Staratschek-Jox A; Kotkowski S; Belge G; Rüdiger T; Bullerdiek J; Diehl V; Wolf J
    Am J Pathol; 2000 Jan; 156(1):209-16. PubMed ID: 10623669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein-Barr virus.
    Siebert JD; Ambinder RF; Napoli VM; Quintanilla-Martinez L; Banks PM; Gulley ML
    Hum Pathol; 1995 Nov; 26(11):1191-5. PubMed ID: 7590691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection.
    Quintanilla-Martinez L; Fend F; Moguel LR; Spilove L; Beaty MW; Kingma DW; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1999 Oct; 23(10):1233-40. PubMed ID: 10524524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease.
    Reynolds DJ; Banks PM; Gulley ML
    Am J Pathol; 1995 Feb; 146(2):379-88. PubMed ID: 7531953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus.
    Herbst H; Samol J; Foss HD; Raff T; Niedobitek G
    J Pathol; 1997 Jul; 182(3):299-306. PubMed ID: 9349232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin's lymphoma.
    Lee IS; Kim SH; Song HG; Park SH
    Int J Hematol; 2003 May; 77(4):330-5. PubMed ID: 12774919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
    Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
    Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.